Correlation Between Pfizer and BAKER

Can any of the company-specific risk be diversified away by investing in both Pfizer and BAKER at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and BAKER into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pfizer Inc and BAKER HUGHES A, you can compare the effects of market volatilities on Pfizer and BAKER and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of BAKER. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and BAKER.

Diversification Opportunities for Pfizer and BAKER

0.7

Correlation Coefficient

Pfizer  BAKER

Poor diversification

The 3 months correlation between Pfizer and BAKER is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and BAKER HUGHES A in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BAKER HUGHES A and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with BAKER. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BAKER HUGHES A has no effect on the direction of Pfizer i.e., Pfizer and BAKER go up and down completely randomly.

Pair Corralation between Pfizer and BAKER

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the BAKER. In addition to that, Pfizer is 1.8 times more volatile than BAKER HUGHES A. It trades about -0.05 of its total potential returns per unit of risk. BAKER HUGHES A is currently generating about 0.01 per unit of volatility. If you would invest  8,036  in BAKER HUGHES A on September 21, 2024 and sell it today you would earn a total of  22.00  from holding BAKER HUGHES A or generate 0.27% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	83.18%
Values	Daily Returns

Pfizer Inc  vs.  BAKER HUGHES A

Pfizer Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

BAKER HUGHES A

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days BAKER HUGHES A has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, BAKER is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Pfizer and BAKER

The main advantage of trading using opposite Pfizer and BAKER positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, BAKER can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BAKER will offset losses from the drop in BAKER's long position.

The idea behind Pfizer Inc and BAKER HUGHES A pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.